These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434 [TBL] [Abstract][Full Text] [Related]
8. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621 [TBL] [Abstract][Full Text] [Related]
9. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993 [TBL] [Abstract][Full Text] [Related]
10. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma. Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941 [TBL] [Abstract][Full Text] [Related]
12. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423 [TBL] [Abstract][Full Text] [Related]
13. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey. Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798 [TBL] [Abstract][Full Text] [Related]
14. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Suzuki S; Yamane T; Mohri M; Kaneko A Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012 [TBL] [Abstract][Full Text] [Related]
15. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578 [TBL] [Abstract][Full Text] [Related]
16. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042 [TBL] [Abstract][Full Text] [Related]